Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Using Tumor Genomics to Predict Axillary Response to Chemotherapy in Breast Cancer

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013 9;310(14):1455–61. https://doi.org/10.1001/jama.2013.278932. PMID: 24101169; PMCID: PMC4075763.

  2. Pease AM, Riba LA, Gruner RA, et al. Oncotype DX® Recurrence score as a predictor of response to neoadjuvant chemotherapy. Ann Surg Oncol. 2019;26(2):366–371. https://doi.org/10.1245/s10434-018-07107-8. Epub 2018 Dec 12. PMID: 30542840.

    Article  PubMed  Google Scholar 

  3. Pardo JA, Fan B, Mele A, et al. The role of oncotype DX recurrence score in predicting axillary response after neoadjuvant chemotherapy in breast cancer. Ann Surg Oncol. https://doi.org/10.1245/s10434-020-09382-w.

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, BreastCare Center, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA

    Ted A. James MD, MS & Betty Fan DO

Authors
  1. Ted A. James MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Betty Fan DO
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ted A. James MD, MS.

Ethics declarations

Disclosures

There are no affiliations with or financial involvement in any organization with a direct financial interest in the subject matter or materials discussed in this manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

James, T.A., Fan, B. ASO Author Reflections: Using Tumor Genomics to Predict Axillary Response to Chemotherapy in Breast Cancer. Ann Surg Oncol 28, 1326–1327 (2021). https://doi.org/10.1245/s10434-020-09455-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-09455-w

Search

Navigation